NISLEVO-MK
Overview:
NISLEVO MK Tablets contains Levocetirizine and Montelukast. Levocetirizine prevents the release of allergy chemicals and increase blood supply to the area, and provides relief from the typical symptoms of hay fever. Montelukast blocks another chemical receptor (leukotriene).
- Class
- Dosage
- Indications
- Mechanism of action
NISLEVO-MK Tablets contain Levocetirizine and Montelukast . Levocetirizine is a third-generation non-sedative antihistamine. Montelukast belong to a group called leukotriene receptor antagonists (LTRAs)
NISLEVO- MK Tablets can be used in the treatment of following conditions:
- Allergic rhinitis (hay fever)
- Chronic urticaria (hives)
Levocetirizine works by blocking histamine. As an inverse agonist, levocetirizine decreases H1 receptor activity. Provides relief from typical hay fever symptoms, and prevents the release of other allergy chemicals. Does not prevent the release of histamine from mast cells.
Montelukast binds highly selectively to CysLT type 1 receptors, thereby inhibiting any physiological actions of CysLTs like LTC4, LTD4, and LTE4 at the receptor that may promote asthma or allergic rhinitis.
